Predominance of CIN versus MSI in the development of rectal cancer at young age

BMC Cancer

Volumn 2, Issue , 2002, Pages

  Fernebro, Eva ^a   Halvarsson, Britta ^a   Baldetorp, Bo ^a   Nilbert, Mef ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Flow cytometry; HNPCC; Immunohistochemistry; KRAS; MLH1; MSH2; MSI; p53; Rectal cancer; catenin

Indexed keywords

BETA CATENIN; FLUOROURACIL; FOLINIC ACID; K RAS PROTEIN; OXALIPLATIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; CARRIER PROTEIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DNA; DNA BINDING PROTEIN; MICROSATELLITE DNA; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ADULT; ANEUPLOIDY; ARTICLE; CANCER GRADING; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ONCOGENE K RAS; PLOIDY; POLYMERASE CHAIN REACTION; RECTUM CANCER; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PATHOLOGY; RECTUM TUMOR;

ADULT; ANEUPLOIDY; BETA CATENIN; CARRIER PROTEINS; CHROMOSOME ABERRATIONS; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; RECTAL NEOPLASMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042798448     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-2-25     Document Type: Article

References (27)

1. The National Board of Health and Welfare: Cancer Incidence in Sweden 1999. Stockholm 1999
2. Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453-56
3. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomäki P, Chadwick RB, Käärinen H, Eskelinen M, Jä rvinen H, et al: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998, 338:1481-87
4. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML: The colon cancer burden of genetically defined hereditary nonpolyposis colorectal cancer. Gastroenterology 2001, 121:830-838
5. Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, Fujiwara T, Jen J, Kinzler KW, Wyllie AH, et al: Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995, 1:348-52
6. Brassett C, Joyce JA, Froggatt NJ, Williams G, Furniss D, Walsh S, Millar R, Evans DG, Maher ER: Microsatellite instability in early onset and familial colorectal cancer. J Med Genet 1996, 33:981-985
7. Capozzi E, Della Puppa L, Fornasarig M, Pedroni M, Boiocchi M, Viel A: Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer. Eur J Cancer 1999, 35:289-95
8. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000, 342:69-77
9. Naidoo R, Tarin M, Chetty R, Phil D: A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age. Am J Gastroeneterol 2000, 95:3266-75
10. Su JH, Lim SD, Kim JC, Hong SH, Kang GH: Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old. Dis Colon Rectum 2002, 45:219-228
11. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature 1997, 386:623-627
12. Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin S-A, et al: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 2001, 159:2107-2116
13. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, McDonnell SK, Schaid DJ, Walsh Vockley C, Michels VV, et al: Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998, 58:1713-18
14. Lothe R, Peltomäki P, Meling GI, Aaltonen LA, Nyström-Lathi M, Pylkkanen L, Heimdal K, Andersen TI, Möller P, Rognum TO, et al: Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993, 53:5849-52
15. Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, House A, Iacopetta B: p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res 1997, 3:1405-11
16. Nilbert M, Planck M, Fernebro E, Borg A,̊ Johnson A: Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Eur J Cancer 1999, 35:942-945
17. Bleeker WA, Hayes VM, Karrenbeld A, Hofstra RM, Hermans J, Buys CC, Plukk JT: Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Am J Gastroenterol 2000, 95:2953-7
18. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RAEM, Moriya Y, van de Velde CJH, van Krieken JHJM: Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001, 195:171-178
19. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, et al: A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248-5257
20. Marcus VA, Madlensky L, Gryfe R, Kim H, Millar A, Temple LKF, Hsieh E, Hiruki T, Narod S, Bapat BV, et al: Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999, 23:1248-55
21. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, et al: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043-1048
22. Mutter GL, Wada H, Faquin WC, Enomoto T: K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis. Mol Pathol 1999, 52:257-62
23. Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, et al: Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 2001, 158:1517-21
24. Andreyev HJN, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, et al: Kirsten ras mutations in patients with colorectal cancer: the "RASCAL II" study. Br J Cancer 2001, 85:692-96
25. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ, Kinsella AR: B-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 1999, 82:504-511
26. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW: Mutational analysis of the APC/B-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998, 58:1130-34
27. Miyaki M, Iijma T, Kimura J, Yasuno M, Mori T, Hayasi Y, Koike M, Shitara N, Iwama T, Kuroki T: Frequent mutation of B-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 1999, 59:4506-9